Ecosystem services and biodiversity in urban environments

Here I consider the effect of land-use change by urbanisation on organic carbon (C) storage within three study areas in north-east England. I found that the contiguous urban extent of Darlington, Durham and Newcastle had increased by 67%, 229% and 65% respectively between 1945 and the present, and that the total C stored within the land occupied had decreased by around one-third. Decreases in C storage have occurred due to the replacement of agricultural land with urban land-uses of lower C storage value; notably, there have been large gains in low- to moderate-density residential areas and commercial land-uses. The greatest loss of C has been from the soil C pool, as the surface area occupied by soil, and soil depth, are greatly reduced in built urban land-uses compared to agriculture. Next, I investigated the spatial congruence between C storage and biodiversity in an urbanised area, using birds as a biodiversity indicator taxon. I found that land-uses with greatest C storage value per unit area also had the highest bird species richness and diversity, whilst land-uses with lowest C storage value had among the lowest bird species richness and diversity. However, the relationship was not straightforward; most notably, species richness and diversity were high in low- to moderate-density housing, despite these land-uses having low C storage value. Beta-diversity increased among land-uses, further highlighting the biodiversity value of some moderate to low C storage land-uses within the urban matrix. When not categorised by land-use, the overall spatial relationship between C storage and species richness and diversity was positive, and tree and woody vegetation C pools had the strongest positive relationship with bird species richness and diversity. I discuss the results with respect to UK urban planning options aimed at meeting both C emissions and biodiversity conservation targets, whilst also considering the continued well-being of increasing urban human populations

The avian dawn chorus across Great Britain: using new technology to study breeding bird song

The avian dawn chorus is a period of high song output performed daily around sunrise during the breeding season. Singing at dawn is of such significance to birds that they remain motivated to do so amid the noise of numerous others. Yet, we still do not fully understand why the dawn chorus exists. Technological advances in recording equipment, data storage and sound analysis tools now enable collection and scrutiny of large acoustic datasets, encouraging research on sound-producing organisms and promoting ‘the soundscape’ as an indicator of ecosystem health. Using an unrivalled dataset of dawn chorus recordings collected during this thesis, I explore the chorus throughout Great Britain with the prospect of furthering our understanding and appreciation of this daily event. I first evaluate the performance of four automated signal recognition tools (‘recognisers’) when identifying the singing events of target species during the dawn chorus, and devise a new ensemble approach that improves detection of singing events significantly over each of the recognisers in isolation. I then examine daily variation in the timing and peak of the chorus across the country in response to minimum overnight temperature. I conclude that cooler temperatures result in later chorus onset and peak the following dawn, but that the magnitude of this effect is greater at higher latitude sites with cooler and less variable overnight temperature regimes. Next, I present evidence of competition for acoustic space during the dawn chorus between migratory and resident species possessing similar song traits, and infer that this may lead either to fine-scale temporal partitioning of song, such that each competitor maintains optimal output, or to one competitor yielding. Finally, I investigate day-to-day attenuation of song during the leaf-out period from budburst through to full-leaf in woodland trees, and establish the potential for climate-driven advances in leaf-out phenology to attenuate song if seasonal singing activity in birds has not advanced to the same degree. I find that gradual attenuation of sound through the leaf-out process is dependent on the height of the receiver, and surmise that current advances in leaf-out phenology are unlikely to have undue effect on song propagation. This project illustrates the advantage of applying new technology to ecological studies of complex acoustic environments, and highlights areas in need of improvement, which is essential if we are to comprehend and preserve our natural soundscapes

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

SummaryBackground Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatoryactions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19.Methods In this randomised, controlled, open-label, adaptive platform trial (Randomised Evaluation of COVID-19Therapy [RECOVERY]), several possible treatments were compared with usual care in patients admitted to hospitalwith COVID-19 in the UK. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients wererandomly allocated to either usual standard of care alone or usual standard of care plus azithromycin 500 mg once perday by mouth or intravenously for 10 days or until discharge (or allocation to one of the other RECOVERY treatmentgroups). Patients were assigned via web-based simple (unstratified) randomisation with allocation concealment andwere twice as likely to be randomly assigned to usual care than to any of the active treatment groups. Participants andlocal study staff were not masked to the allocated treatment, but all others involved in the trial were masked to theoutcome data during the trial. The primary outcome was 28-day all-cause mortality, assessed in the intention-to-treatpopulation. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936.Findings Between April 7 and Nov 27, 2020, of 16 442 patients enrolled in the RECOVERY trial, 9433 (57%) wereeligible and 7763 were included in the assessment of azithromycin. The mean age of these study participants was65·3 years (SD 15·7) and approximately a third were women (2944 [38%] of 7763). 2582 patients were randomlyallocated to receive azithromycin and 5181 patients were randomly allocated to usual care alone. Overall,561 (22%) patients allocated to azithromycin and 1162 (22%) patients allocated to usual care died within 28 days(rate ratio 0·97, 95% CI 0·87–1·07; p=0·50). No significant difference was seen in duration of hospital stay (median10 days [IQR 5 to >28] vs 11 days [5 to >28]) or the proportion of patients discharged from hospital alive within 28 days(rate ratio 1·04, 95% CI 0·98–1·10; p=0·19). Among those not on invasive mechanical ventilation at baseline, nosignificant difference was seen in the proportion meeting the composite endpoint of invasive mechanical ventilationor death (risk ratio 0·95, 95% CI 0·87–1·03; p=0·24).Interpretation In patients admitted to hospital with COVID-19, azithromycin did not improve survival or otherprespecified clinical outcomes. Azithromycin use in patients admitted to hospital with COVID-19 should be restrictedto patients in whom there is a clear antimicrobial indication